94 related articles for article (PubMed ID: 7832484)
1. Identification of a specific mammalian melanocortin receptor antagonist.
Tatro JB; Entwistle ML
Ann N Y Acad Sci; 1994 Oct; 739():315-9. PubMed ID: 7832484
[No Abstract] [Full Text] [Related]
2. Agouti antagonism of melanocortin binding and action in the B16F10 murine melanoma cell line.
Blanchard SG; Harris CO; Ittoop OR; Nichols JS; Parks DJ; Truesdale AT; Wilkison WO
Biochemistry; 1995 Aug; 34(33):10406-11. PubMed ID: 7544613
[TBL] [Abstract][Full Text] [Related]
3. Agouti protein is an antagonist of the melanocyte-stimulating-hormone receptor.
Lu D; Willard D; Patel IR; Kadwell S; Overton L; Kost T; Luther M; Chen W; Woychik RP; Wilkison WO
Nature; 1994 Oct; 371(6500):799-802. PubMed ID: 7935841
[TBL] [Abstract][Full Text] [Related]
4. Evidence for the internalization of [125I-Tyr2, Nle4, D-Phe7] alpha-MSH following binding to the MSH receptor of B16 murine melanoma cells.
Adams G; Olivier GW; Branch SK; Moss SH; Notarianni LJ; Pouton CW
Ann N Y Acad Sci; 1993 May; 680():440-1. PubMed ID: 8390163
[No Abstract] [Full Text] [Related]
5. Adenosine inhibits alpha-melanocyte-stimulating hormone release from frog pituitary melanotrophs via an A1 receptor subtype negatively coupled to adenylate cyclase.
Chartrel N; Tonon MC; Lamacz M; Vaudry H
Ann N Y Acad Sci; 1993 May; 680():470-2. PubMed ID: 8390170
[No Abstract] [Full Text] [Related]
6. Regulation of the rat proopiomelanocortin gene expression in AtT-20 cells. II: Effects of the pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal polypeptide.
Aoki Y; Iwasaki Y; Katahira M; Oiso Y; Saito H
Endocrinology; 1997 May; 138(5):1930-4. PubMed ID: 9112389
[TBL] [Abstract][Full Text] [Related]
7. A cleavable biotinylated photoactivable derivative of alpha-MSH. Its application to the characterization and isolation of the alpha-MSH receptor.
Ahmed AR; Olivier GW; Branch SK; Moss SH; Notarianni LJ; Pouton CW
Ann N Y Acad Sci; 1993 May; 680():442-4. PubMed ID: 8390164
[No Abstract] [Full Text] [Related]
8. Receptors for melanocyte-stimulating hormone on melanoma cells.
Eberle AN; Siegrist W; Bagutti C; Chluba-De Tapia J; Solca F; Wikberg JE; Chhajlani V
Ann N Y Acad Sci; 1993 May; 680():320-41. PubMed ID: 8390156
[No Abstract] [Full Text] [Related]
9. Isoform-specific sensitization of adenylyl cyclase activity by prior activation of inhibitory receptors: role of beta gamma subunits in transducing enhanced activity of the type VI isoform.
Thomas JM; Hoffman BB
Mol Pharmacol; 1996 May; 49(5):907-14. PubMed ID: 8622641
[TBL] [Abstract][Full Text] [Related]
10. Cloning and expression of a Ca(2+)-inhibitable adenylyl cyclase from NCB-20 cells.
Yoshimura M; Cooper DM
Proc Natl Acad Sci U S A; 1992 Aug; 89(15):6716-20. PubMed ID: 1379717
[TBL] [Abstract][Full Text] [Related]
11. Regulation of adenylyl cyclase in polarized renal epithelial cells by G protein-coupled receptors.
Okusa MD; Huang L; Momose-Hotokezaka A; Huynh LP; Mangrum AJ
Am J Physiol; 1997 Dec; 273(6):F883-91. PubMed ID: 9435676
[TBL] [Abstract][Full Text] [Related]
12. RGS2 regulates signal transduction in olfactory neurons by attenuating activation of adenylyl cyclase III.
Sinnarajah S; Dessauer CW; Srikumar D; Chen J; Yuen J; Yilma S; Dennis JC; Morrison EE; Vodyanoy V; Kehrl JH
Nature; 2001 Feb; 409(6823):1051-5. PubMed ID: 11234015
[TBL] [Abstract][Full Text] [Related]
13. Acteoside inhibits alpha-MSH-induced melanin production in B16 melanoma cells by inactivation of adenyl cyclase.
Song HS; Sim SS
J Pharm Pharmacol; 2009 Oct; 61(10):1347-51. PubMed ID: 19814867
[TBL] [Abstract][Full Text] [Related]
14. Phorbol ester stimulation of the type I and type III adenylyl cyclases in whole cells.
Choi EJ; Wong ST; Dittman AH; Storm DR
Biochemistry; 1993 Mar; 32(8):1891-4. PubMed ID: 7680573
[TBL] [Abstract][Full Text] [Related]
15. Calmodulin-binding peptides interfere with melanocyte-stimulating hormone receptor activity and stimulate adenosine 3',5'-monophosphate production in M2R mouse melanoma cells.
Eshel Y; Salomon Y
Endocrinology; 1994 Jan; 134(1):177-85. PubMed ID: 8275931
[TBL] [Abstract][Full Text] [Related]
16. Regulation of forskolin interactions with type I, II, V, and VI adenylyl cyclases by Gs alpha.
Sutkowski EM; Tang WJ; Broome CW; Robbins JD; Seamon KB
Biochemistry; 1994 Nov; 33(43):12852-9. PubMed ID: 7947691
[TBL] [Abstract][Full Text] [Related]
17. Molecular and pharmacological characterisation of the MSH-R alleles in Swiss cattle breeds.
Graphodatskaya D; Joerg H; Stranzinger G
J Recept Signal Transduct Res; 2002; 22(1-4):421-30. PubMed ID: 12503631
[TBL] [Abstract][Full Text] [Related]
18. Development of self-referencing oxygen microsensor and its application to single pancreatic HIT cells: effects of adenylate cyclase activator forskolin on oxygen consumption.
Jung SK; Hammar K; Smith PJ
Biol Bull; 2000 Oct; 199(2):197-8. PubMed ID: 11081733
[No Abstract] [Full Text] [Related]
19. Synthesis and receptor binding analysis of thirteen oligomeric alpha-MSH analogs.
Brandenburger Y; Rose K; Bagutti C; Eberle AN
J Recept Signal Transduct Res; 1999; 19(1-4):467-80. PubMed ID: 10071778
[TBL] [Abstract][Full Text] [Related]
20. Long term orexigenic effect of a novel melanocortin 4 receptor selective antagonist.
Skuladottir GV; Jonsson L; Skarphedinsson JO; Mutulis F; Muceniece R; Raine A; Mutule I; Helgason J; Prusis P; Wikberg JE; Schiöth HB
Br J Pharmacol; 1999 Jan; 126(1):27-34. PubMed ID: 10051117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
